These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 28526535

  • 1. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
    Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
    [Abstract] [Full Text] [Related]

  • 3. The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement.
    Li DT, Yang Q, Xia CY, Zhang YF, Cai Y, Wu SQ, Jiang Q, Hu P.
    Clin Exp Med; 2024 Aug 06; 24(1):177. PubMed ID: 39105936
    [Abstract] [Full Text] [Related]

  • 4. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL, Zhao SL.
    Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902
    [Abstract] [Full Text] [Related]

  • 5. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
    Samadli S, Liu FF, Mammadov G, Wang JJ, Liu HH, Wu YF, Luo HH, Wu Y, Chen WX, Zhang DD, Wei W, Hu P.
    Pediatr Rheumatol Online J; 2019 Jul 31; 17(1):53. PubMed ID: 31366406
    [Abstract] [Full Text] [Related]

  • 6. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 31; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 7. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 May 31; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 8. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Indian J Pediatr; 2019 Mar 31; 86(3):250-255. PubMed ID: 30159809
    [Abstract] [Full Text] [Related]

  • 9. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.
    Niu MM, Jiang Q, Ruan JW, Liu HH, Chen WX, Qiu Z, Fan GZ, Li RX, Wei W, Hu P.
    Clin Exp Med; 2021 Nov 31; 21(4):633-643. PubMed ID: 33839960
    [Abstract] [Full Text] [Related]

  • 10. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y, Qian SY, Yuan Y, Wang Q, Gao L, Chen X, Yu X, Zhen Z.
    Clin Chim Acta; 2020 Jul 31; 506():222-227. PubMed ID: 32156603
    [Abstract] [Full Text] [Related]

  • 11. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 31; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 12. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Dec 31; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 13. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 31; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

  • 14. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 31; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 15. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
    Fujimaru T, Ito S, Masuda H, Oana S, Kamei K, Ishiguro A, Kato H, Abe J.
    Cytokine; 2014 Dec 31; 70(2):156-60. PubMed ID: 25082649
    [Abstract] [Full Text] [Related]

  • 16. Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease.
    Sakurai Y, Takatsuka H, Onaka M, Takada M, Nishino M.
    Int Arch Allergy Immunol; 2014 Dec 31; 165(2):111-8. PubMed ID: 25401215
    [Abstract] [Full Text] [Related]

  • 17. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 18. The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease.
    Wang QQ, Zheng LY, Zhao S.
    Turk J Pediatr; 2023 Mar 21; 65(4):640-649. PubMed ID: 37661679
    [Abstract] [Full Text] [Related]

  • 19. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul 21; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 20. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
    Si F, Wu Y, Gao F, Feng S, Liu R, Yi Q.
    Clin Exp Med; 2017 Nov 21; 17(4):451-457. PubMed ID: 28108813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.